Surprise: Did Otonomy bring its lead ear drug back from the dead?
Shares of Otonomy $OTIC went into blastoff mode after the market closed on Wednesday, as researchers for the biotech reported positive Phase III data for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
